- Home
- WRN vs TKNO Comparison
WRN vs TKNO Comparison
Compare WRN & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRN
- TKNO
- Stock Information
- Founded
- WRN 2006
- TKNO 1996
- Country
- WRN Canada
- TKNO United States
- Employees
- WRN N/A
- TKNO N/A
- Industry
- WRN Metal Mining
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- WRN Basic Materials
- TKNO Health Care
- Exchange
- WRN Nasdaq
- TKNO Nasdaq
- Market Cap
- WRN 249.2M
- TKNO 244.7M
- IPO Year
- WRN N/A
- TKNO 2021
- Fundamental
- Price
- WRN $1.21
- TKNO $4.92
- Analyst Decision
- WRN Strong Buy
- TKNO Buy
- Analyst Count
- WRN 1
- TKNO 2
- Target Price
- WRN $4.25
- TKNO $5.00
- AVG Volume (30 Days)
- WRN 179.6K
- TKNO 133.3K
- Earning Date
- WRN 11-01-2024
- TKNO 11-07-2024
- Dividend Yield
- WRN N/A
- TKNO N/A
- EPS Growth
- WRN N/A
- TKNO N/A
- EPS
- WRN N/A
- TKNO N/A
- Revenue
- WRN N/A
- TKNO $34,940,000.00
- Revenue This Year
- WRN N/A
- TKNO $3.22
- Revenue Next Year
- WRN N/A
- TKNO $14.88
- P/E Ratio
- WRN N/A
- TKNO N/A
- Revenue Growth
- WRN N/A
- TKNO N/A
- 52 Week Low
- WRN $0.95
- TKNO $1.16
- 52 Week High
- WRN $1.66
- TKNO $5.46
- Technical
- Relative Strength Index (RSI)
- WRN 51.60
- TKNO 55.60
- Support Level
- WRN $1.20
- TKNO $4.47
- Resistance Level
- WRN $1.31
- TKNO $4.93
- Average True Range (ATR)
- WRN 0.05
- TKNO 0.40
- MACD
- WRN -0.00
- TKNO -0.01
- Stochastic Oscillator
- WRN 28.57
- TKNO 58.77
About WRN Western Copper and Gold Corporation
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.